.Beta.-Hydroxyisovaleric Acid

.Beta.-Hydroxyisovaleric Acid

SCHEMBL2002182

C1CCCCC1.CC(C)(O)CC(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 1/20 0.57
CHRM1 P11229 1/20 0.57
TBXA2R P21731 1/20 0.57
ADRA1A P35348 1/20 0.57
TSHR P16473 2/20 0.48
CYP2C19 P33261 2/20 0.48
HIF1A Q16665 2/20 0.48
CYP2D6 P10635 1/20 0.48
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.42
FFAR1 O14842 1/20 0.42
CPT2 P23786 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
FFAR3 O14843 1/20 0.40
PIK3CD O00329 1/20 0.37
ACLY P53396 2/20 0.36
SLC13A5 Q86YT5 2/20 0.35
TET2 Q6N021 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110217759-A1 STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS VSL PHARMACEUTICALS, INC. (IT) 2011-09-08 US disclosed
US-7959911-B2 Enzymatic polypeptide for use in the treatment of defects in ble metabolism VSL PHARMACEUTICALS INC. (US) 2011-06-14 US disclosed
EP-1721527-B1 Lipase and use of same for improving doughs and baked products DANISCO (DK) 2010-06-09 EP disclosed
US-RE41276-E1 STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS VSL PHARMACEUTICALS, INC. (US) 2010-04-27 US disclosed
EP-0977869-B2 LIPASE AND USE OF SAME FOR IMPROVING DOUGHS AND BAKED PRODUCTS DANISCO (DK) 2008-11-12 EP disclosed
US-7371423-B2 Method for preparing flour doughs and products made from such doughs using lipase DANISCO, A/S (DK) 2008-05-13 US disclosed
EP-1721527-A2 Lipase and use of same for improving doughs and baked products DANISCO A/S (DK) 2006-11-15 EP disclosed
EP-1679373-A2 Lipase and use of same for improving doughs and baked products DANISCO A/S (DK) 2006-07-12 EP disclosed
EP-1433852-B1 Use of lipase for improving doughs and baked products DANISCO (DK) 2006-06-28 EP disclosed
EP-1466980-B1 Lipase and use of same for improving doughs and baked products DANISCO (DK) 2006-06-28 EP disclosed
US-20040071853-A1 For improving rheological properties of a flour dough and the quality of bread, alimentary paste products, noodles and cakes DUPONT NUTRITION BIOSCIENCES APS (DK) 2004-04-15 US disclosed
EP-0795604-B1 Strains of bacteria with altered metabolism of bile acids and their use DE SIMONE CLAUDIO (IT) 2003-08-06 EP disclosed
US-20030108641-A1 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability DANISCO A/S (DK) 2003-06-12 US disclosed
US-20030082791-A1 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids VSL PHARMACEUTICALS INC. 2003-05-01 US disclosed
EP-0973399-B1 IMPROVED METHOD FOR PREPARING FLOUR DOUGHS AND PRODUCTS MADE FROM SUCH DOUGHS USING GLYCEROL OXIDASE DANISCO (DK) 2002-07-17 EP disclosed
US-6406723-B1 ADJUSTING RHEOLOGY PROPERTIES DANISCO A/S (DK) 2002-06-18 US disclosed
EP-1193314-A1 Lipase and use of same for improving doughs and baked products DANISCO A/S (DK) 2002-04-03 EP disclosed
US-20010012629-A1 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids CLAUDIO DESIMONE (IT) 2001-08-09 US disclosed
US-6225104-B1 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids CAVALIERE VESELY RENATA MARIA (IT) 2001-05-01 US disclosed
EP-0795604-A2 Strains of bacteria with altered metabolism of bile acids and their use Cavaliere Vesely, Renata Maria Anna (IT) 1997-09-17 EP disclosed